Ikarian Capital, LLC Vigil Neuroscience, Inc. Transaction History
Ikarian Capital, LLC
- $606 Million
- Q4 2024
A detailed history of Ikarian Capital, LLC transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 500,000 shares of VIGL stock, worth $1.13 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
500,000Holding current value
$1.13 Million% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding VIGL
# of Institutions
53Shares Held
26.9MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$13.2 Million1.62% of portfolio
-
Northpond Ventures, LLC4.21MShares$9.52 Million51.65% of portfolio
-
Siren, L.L.C. New York, NY1.99MShares$4.5 Million0.15% of portfolio
-
Bvf Inc San Francisco, CA1.81MShares$4.1 Million0.11% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.51MShares$3.41 Million0.0% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $63.9M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...